SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-12-084453
Filing Date
2012-12-17
Accepted
2012-12-17 07:10:46
Documents
6
Period of Report
2012-12-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a12-29566_18k.htm 8-K 40652
2 EX-4.1 a12-29566_1ex4d1.htm EX-4.1 125529
3 EX-10.1 a12-29566_1ex10d1.htm EX-10.1 266957
4 EX-99.1 a12-29566_1ex99d1.htm EX-99.1 21538
5 GRAPHIC g295661mmi001.jpg GRAPHIC 3409
6 GRAPHIC g295661mmi002.jpg GRAPHIC 2014
  Complete submission text file 0001104659-12-084453.txt   463788
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 121267292
SIC: 2834 Pharmaceutical Preparations